Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lara Šošić, Marta Paolucci, Stephan Flory, Fadi Jebbawi, Thomas M. Kündig & Pål Johansen. (2023) Allergen immunotherapy: progress and future outlook. Expert Review of Clinical Immunology 19:7, pages 745-769.
Read now
Read now
Articles from other publishers (15)
Shaobing Xie, Sijie Jiang, Ruohao Fan, Kelei Gao, Jian Shui, Fengjun Wang, Zhihai Xie, Hua Zhang & Weihong Jiang. (2023) Elevated body mass index increased the risk of recurrence in Chinese patients with chronic rhinosinusitis. American Journal of Otolaryngology 44:4, pages 103841.
Crossref
Crossref
Sara Costa Gomes, Tim Delemarre, Gabriele Holtappels, Thibaut Van Zele, Lara Derycke, Ellen Bonne, Anne-Sophie Eeckels, Nan Zhang, Richard Louis Voegels & Claus Bachert. (2022) Olfaction in nasal polyp patients after Reboot surgery: an endotype-based prospective study. European Archives of Oto-Rhino-Laryngology 280:6, pages 2821-2830.
Crossref
Crossref
Marina Blanco-Aparicio, Javier Domínguez-Ortega, Carolina Cisneros, Carlos Colás, Francisco Casas, Alfonso del Cuvillo, Isam Alobid, Santiago Quirce & Joaquim Mullol. (2023) Consensus on the management of united airways disease with type 2 inflammation: a multidisciplinary Delphi study. Allergy, Asthma & Clinical Immunology 19:1.
Crossref
Crossref
Cosimo Galletti, Maria Antonietta Barbieri, Francesco Ciodaro, Francesco Freni, Francesco Galletti, Edoardo Spina & Bruno Galletti. (2023) Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care. Pharmaceuticals 16:4, pages 630.
Crossref
Crossref
Matteo Gelardi, Rossana Giancaspro, Michele Cassano & Domenico Ribatti. (2023) Nasal cytology and histology in CRSwNP: Two sides of the same coin. Frontiers in Medicine 10.
Crossref
Crossref
Kelly L. Staricha, Hawa M. Ali & Janalee K. Stokken. (2023) State of the Art Medical Management of Nasal Polyps. American Journal of Rhinology & Allergy 37:2, pages 153-161.
Crossref
Crossref
Matteo Gelardi, Rossana Giancaspro, Gianluca Ronca, Vitaliano Nicola Quaranta, Antonio Daloiso, Corso Bocciolini, Mario Notargiacomo, Cristiano Lingua, Pietro Pecoraro, Lucia Iannuzzi & Michele Cassano. (2023) Correlation between chronic rhinosinusitis with nasal polyposis (CRSwNP) severity and asthma control. American Journal of Otolaryngology 44:2, pages 103701.
Crossref
Crossref
Toshiyuki Matsuyama, Hideyuki Takahashi, Hiroe Tada & Kazuaki Chikamatsu. (2022) Circulating T Cell Subsets and ILC2s are Altered in Patients With Chronic Rhinosinusitis With Nasal Polyps After Dupilumab Treatment. American Journal of Rhinology & Allergy 37:1, pages 58-64.
Crossref
Crossref
Maryia Zhdanava, Briana Ndife, Dominic Pilon, Carmine Rossi, Maude Vermette-Laforme, Patrick Lefebvre & Jeffrey D. Suh. (2022) Economic Burden Associated With Nasal Polyposis Recurrence Among Commercially Insured Patients in the United States. Otolaryngology–Head and Neck Surgery 168:1, pages 65-73.
Crossref
Crossref
C. Yoonhee Ryder, Mark A. Zacharek & Christopher M. Welch. (2023) Improvement of Suspected Eosinophilic Otitis Media with Targeted Biologic Therapy. Otology & Neurotology Publish Ahead of Print.
Crossref
Crossref
Austin R. Swisher, Rijul S. Kshirsagar, Nithin D. AdappaJonathan Liang. (2021)
Dupilumab Adverse Events in Nasal Polyp Treatment: Analysis of
FDA
Adverse Event Reporting System
. The Laryngoscope 132:12, pages 2307-2313.
Crossref
Crossref
Lucia De Prado Gomez, PharmD, MSc, Asif H. Khan, MBBS, MPH, Anju T. Peters, MD, Claus Bachert, MD, PhD, Martin Wagenmann, MD, Enrico Heffler, MD, PhD, Claire Hopkins, BMBCh, Peter W. Hellings, MD, PhD, Mei Zhang, PhD, Jun Xing, PhD, Paul Rowe, MD & Juby A. Jacob-Nara, MD, MPH, DHSc. (2022) Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design. American Journal of Rhinology & Allergy 36:6, pages 788-795.
Crossref
Crossref
Marcus Maurer, Sarbjit S. Saini, Kristi McLendon, Paul Wabnitz, Sunghyun Kim, Keumyoung Ahn, Suyoung Kim, Sewon Lee & Clive Grattan. (2022) Pharmacokinetic equivalence of CT‐P39 and reference omalizumab in healthy individuals: A randomised, double‐blind, parallel‐group, Phase 1 trial. Clinical and Translational Allergy 12:11.
Crossref
Crossref
Fang Zhang, Zhenhang Xu, Xi He, Yi Sun, Chong Zhao & Jianhui Zhang. (2022) Increased B Cell-Activating Factor Expression Is Associated with Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps. Mediators of Inflammation 2022, pages 1-11.
Crossref
Crossref
Zahra Chegini, Mojtaba Didehdar, Amin Khoshbayan, Jafar Karami, Milad Yousefimashouf & Aref shariati. (2022) The role of Staphylococcus aureus enterotoxin B in chronic rhinosinusitis with nasal polyposis. Cell Communication and Signaling 20:1.
Crossref
Crossref